Research

Remdesivir proves effective

“Game-Changer” treatment for patients with COVID-19

“Game-Changer” treatment for patients with COVID-19

On April 29, 2020, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, reportedOpens in new window that data from an international clinical trial testing the broad-spectrum antiviral drug remdesivir in around 1,090 patients showed “quite good news” and should result in a new standard of care for COVID-19 patients.

Remdesivir was developed through an academic-corporate partnership between Gilead Sciences and the Baric Lab at the UNC Gillings School of Global Public HealthOpens in new window. The biopharmaceutical company sought the talents of a research team led by Ralph Baric,Opens in new window the William R. Kenan Jr. Distinguished Professor of Epidemiology, who has studied coronaviruses for more than 30 years and pioneered rapid-response approaches for the study of emerging viruses and the development of therapeutics.

“This is a game-changer for the treatment of patients with COVID-19,” Baric said upon hearing the results of the clinical trial. “Remdesivir provides an effective treatment strategy for the many infected individuals around the globe.”

Read the complete Carolina Story…Opens in new window

Carolina on the Frontlines

Learn more about Carolina’s ongoing COVID-19 research and what you can do to help.

Accelerate COVID-19 Research at Carolina

Carolina on the Frontlines

UNC-Chapel Hill is on the frontlines of the COVID-19 pandemic. View the ways you can immediately support Carolina researchers, caregivers and students who drive change, accelerate impact and provide a future for us all.

Support Carolina on the Frontlines

UNC Gillings School of Global Public Health

Readers Also Viewed...

Research

Grant arms UNC-Chapel Hill with technology to accelerate COVID-19 research

A game-changing grant in a global pandemic

Health

The Importance of Face Masks

Limiting the transmission of COVID-19

Community

Emergency Preparedness, Ethics and Equity Speaker Series

Fostering inclusive excellence during turbulent times

Health

Monitoring asymptomatic COVID-19 cases

Partnering with state and local agencies to assess COVID-19 prevalence

Ralph Baric
Research

In Search of the Most Effective COVID-19 Therapeutics

Ralph Baric and his team are testing hundreds of existing compounds against COVID-19 for researchers and labs across the world, in search of the most effective therapeutics.

Rachel Noble
Research

Testing Water Systems for COVID-19

UNC-Chapel Hill researcher Rachel Noble is studying the transmissibility of COVID-19 through water and the environment.